First successful case of platinum‐based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations

First successful case of platinum‐based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations

Introduction Deoxyribonucleic acid repair gene mutations are now being studied in a variety of solid tumors, with the hope of predicting prognosis, pathogenesis, and treatment outcomes. Case presentation We report the case of a Japanese patient with advanced castration‐resistant prostate cancer who...

Full description

Bibliographic Details
Main Authors: Minami Omura, Takeo Kosaka, Eriko Aimono, Kohei Nakamura, Hiroshi Hongo, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:IJU Case Reports
Subjects:
BRCA2 mutation
case report
DNA repair
prognosis
treatment outcome
Online Access:https://doi.org/10.1002/iju5.12383

Internet

https://doi.org/10.1002/iju5.12383

Similar Items